Advertisement
Organisation › Details
MindImmune Therapeutics Inc.
MindImmune is a biotech company targeting the immune system to treat brain disease. The company was founded in 2016 in the US and is based at the University of Rhode Island. It is affiliated with the George & Anne Ryan Institute for Neuroscience, a multidisciplinary research center focused on discovering and developing disease-modifying therapies for neurodegenerative disorders. *
Start | 2016-01-01 established | |
Industry | CNS drug (neurological drug) | |
Industry 2 | drug development | |
Region | Kingston, RI | |
Country | United States (USA) | |
City | n. a. Kingston, RI | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: H. Lundbeck A/S. (5/22/18). "Press Release: Lundbeck Divests Preclinical Research Programs. Two Programs Outside Lundbeck's Areas of Focus Are Transferred to MindImmune Therapeutics, Inc.". Valby. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for MindImmune Therapeutics Inc.
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top